[ad_1]
Masahiro Shang, president of the Japan Institute of Medical Management, suggested that Japan might consider introducing Chinese vaccines so as not to delay vaccination time Image: Reversed from Weibo
In Norway, 23 people recently died after being vaccinated with vaccines developed by Pfizer.inc and BioNTech in Germany, and all the subjects were people over the age of 80. In this regard, Masahiro Shang, Director of the Japan Institute of Medical Management Today stated (15) that because the vaccine has strong side effects, older people should be careful when vaccinating. It is also suggested that the Japanese government should consider the introduction of Chinese vaccines. One more option is another option.
According to a “NORWAY TODAY” report, the Norwegian Medicines Agency announced that there have been 23 deaths related to the Pfizer vaccine and the BioNTech vaccines in China, which turned out to be people over 80 years of age with weakened immunity. Norwegian Medicines Agency chief physician Sigurd frankly said that common side effects of mRNA vaccines include fever, nausea and other symptoms, which can be the cause of death in the elderly. Weak people may not be vaccinated against the new corona vaccine.
China’s “Global Times” reported that, in response to cases of elderly deaths due to vaccination in Norway, Professor Yang Zhanqiu from the Institute of Virology at Wuhan University Medical Department revealed that the largest difference between vaccines of mRNA and inactivated vaccines is that these vaccines are primarily therapeutic. If the patient has been infected or has other diseases, the heterogeneous protein produced by the vaccine can cause allergic reactions and even side effects, which can aggravate the disease, which is a recognized deficiency of mRNA vaccines.
Yang Zhanqiu also pointed out that, compared to Pfizer and other mRNA vaccines, domestic vaccines are currently the main inactivated vaccines, and their safety is much better. In addition, with mature production processes, they are widely used as preventive vaccines, with side effects and the probability of death. In comparison, they are much smaller.
The report mentioned that Japanese Prime Minister Yoshihide Suga had announced that Japan would begin nationwide delivery of vaccines at the end of February, and also reached an agreement with Pfizer in the United States to provide Japan with 60 million vaccines in the first half of this year. In this regard, Masahiro Kami believes that while vaccination is given priority to the elderly, it is not mandatory. He believes that Japan should promote vaccination work for people. After all, everyone’s physical condition is different.
Regarding the large-scale vaccination of domestically produced vaccines in China, Shang Changguang stated that “China is moving fast and is a symbol of youth.” On the other hand, vaccination work in Japan is too slow to start, and it may be April when people can fight. Consider the introduction of Chinese vaccines, one more option means one more option.
However, Chinese experts have recently announced that there are more than 70 side effects of Chinese vaccines, but Chinese authorities immediately withdrew the text and the safety of Chinese vaccines has also been questioned.
Masahiro Shang, president of the Japan Institute of Medical Management, suggested that Japan might consider introducing Chinese vaccines so as not to delay vaccination time.
In Norway, 23 people recently died after being vaccinated with vaccines developed by Pfizer.inc and BioNTech in Germany, all of them people over 80 years of age.
Professor Yang Zhanqiu from the Institute of Virology of the Wuhan University Medical Department revealed that the biggest difference between mRNA vaccines and inactivated vaccines is that this type of vaccine is mainly therapeutic. If the patient is infected or has other diseases, the protein of the opposite sex produced by the vaccine can cause allergies. Reactions and even side effects can aggravate your own condition, which is a recognized deficiency of mRNA vaccines.
The Wuhan pneumonia vaccine developed by Pfizer and BNT has an effective rate of 95%. Photo: Dazhi Image / Reuters (data photo)
[ad_2]